The aim of this paper was to evaluate the ability of multi-marker IE/FACS based on immunomagnetic separation with EpCAM to recover spiked cancer cells across the spectrum of intrinsic subtypes in breast cancer. The gene discussed is EPCAM; the disease is cancer.